https://www.oncnursingnews.com/view/ibrutinib-granted-fda-approval-for-marginal-zone-lymphoma
Ibrutinib Granted FDA Approval for Marginal Zone Lymphoma | Oncology Nursing News
Oct 10, 2026 - The FDA has granted accelerated approval of ibrutinib for treatment of marginal zone lymphona (MZL).
marginal zone lymphomafda approvaloncology nursingibrutinibgranted
https://www.news-medical.net/news/20190401/Study-reveals-investigational-drug-as-effective-treatment-for-relapsed-marginal-zone-lymphoma.aspx?fbclid=IwAR27AhGyRU3EHK3FL59RRrC7JL8OpqlpFRrfzv-lDVQqmg8kMrHMAt5WK0A
Study reveals investigational drug as effective treatment for relapsed marginal zone lymphoma
Jun 18, 2019 - A study at The University of Texas MD Anderson Cancer Center revealed the investigational drug umbralisib as an effective treatment for patients with relapsed...
marginal zone lymphomainvestigational drugas effectivestudyreveals
https://pure.prinsesmaximacentrum.nl/en/publications/treatment-of-extranodal-marginal-zone-lymphoma-of-mucosa-associat/
Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with...
marginal zone lymphomalymphoid tissuetreatmentextranodalmucosa
https://pure.pmu.ac.at/en/publications/extranodal-marginal-zone-lymphoma-of-mucosa-associated-lymphoid-t/
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) with concurrent high...
marginal zone lymphomalymphoid tissueextranodalmucosaassociated